Fujian Medical University

This study tests whether adding an experimental immunotherapy drug (QL1706) to standard chemotherapy and radiation can shrink liver tumors from colon cancer enough to allow surgery. About 30 adults with colon cancer that has spread only to the liver will receive the combination b…

This early-stage trial tests a new 'universal' cell therapy (QH103) for people with a hard-to-treat type of leukemia (B-ALL) that has come back or not responded to standard treatment. The therapy uses donor immune cells engineered to target cancer cells, given after chemotherapy …

This Phase 3 trial tests whether adding an immunotherapy drug (adebrelimab) and a targeted therapy (apatinib) to standard chemotherapy (SOX) can improve outcomes for people with locally advanced stomach cancer that cannot be removed right away. The study will enroll 118 participa…

This study looks at whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard heart failure medications can help people with chronic heart failure walk farther and improve heart function. About 150 adults with reduced heart pumping abil…

This pilot study tests whether a virtual reality gardening program can ease depressive symptoms in 36 older adults (age 60+) with subthreshold depression — a state between normal mood and clinical depression. Participants will use a VR system to plant and care for virtual crops, …

This study tests a computer vision model called PTAIR that helps surgeons identify parathyroid glands and recurrent laryngeal nerves during endoscopic thyroid surgery. About 100 adults with thyroid disease will take part. The model's ability to spot these structures will be compa…

This study tests whether a 12-week blended training program can improve dementia knowledge and skills among primary healthcare providers in China. About 240 workers from community health centers will be randomly assigned to either the training or self-study materials. Researchers…